# Effect of tNGS on CAP Patients With Initial Treatment Failure

> **NCT07472114** · NA · NOT_YET_RECRUITING · sponsor: **Capital Medical University** · enrollment: 524 (estimated)

## Conditions studied

- Community Acquired Pneumonia (CAP)

## Interventions

- **DIAGNOSTIC_TEST:** Targeted next-generation sequencing
- **DIAGNOSTIC_TEST:** Conventional microbiological testing
- **OTHER:** Follow-up at Day 30

## Key facts

- **NCT ID:** NCT07472114
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-10
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-02-28
- **Target enrollment:** 524 (ESTIMATED)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07472114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07472114, "Effect of tNGS on CAP Patients With Initial Treatment Failure". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07472114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*